Current use of daptomycin and systematic therapeutic drug monitoring: Clinical experience in a tertiary care institution
- 1 January 2019
- journal article
- research article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 53 (1) , 40-48
Abstract
No abstract availableKeywords
Funding Information
- Ethics Committee of the Hospital General Universitario Gregorio Marañón (MICRO.HGUGM.2016-017)
This publication has 30 references indexed in Scilit:
- Daptomycin underexposure in a young intravenous drug user who was affected by life-threatening Staphylococcus aureus-complicated skin and soft tissue infection associated with bacteraemiaInfection, 2013
- The Effects of Hypoalbuminaemia on Optimizing Antibacterial Dosing in Critically Ill PatientsClinical Pharmacokinetics, 2011
- Daptomycin pharmacokinetics in critically ill patients receiving continuous venovenous hemodialysisCritical Care Medicine, 2011
- Dosing of daptomycin in intensive care unit patients with acute kidney injury undergoing extended dialysis--a pharmacokinetic studyNephrology Dialysis Transplantation, 2009
- Validated high performance liquid chromatography–UV detection method for the determination of daptomycin in human plasmaJournal of Chromatography B, 2008
- Pharmacokinetics and Tolerability of Daptomycin at Doses up to 12 Milligrams per Kilogram of Body Weight Once Daily in Healthy VolunteersAntimicrobial Agents and Chemotherapy, 2006
- Treatment Failure Resulting from Resistance of Staphylococcus aureus to DaptomycinJournal of Clinical Microbiology, 2006
- Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infectionsJournal of Antimicrobial Chemotherapy, 2005
- In Vivo Pharmacodynamic Activity of DaptomycinAntimicrobial Agents and Chemotherapy, 2004
- Daptomycin Pharmacokinetics and Safety following Administration of Escalating Doses Once Daily to Healthy SubjectsAntimicrobial Agents and Chemotherapy, 2003